Research Summary
Biologic and medical imaging reagents are substances or agents used in various imaging techniques to enhance the visibility and clarity of specific tissues, cells, or molecular targets within the body. These reagents are designed to interact with the target of interest, allowing for improved visualization and detection in medical imaging modalities such as X-ray, magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, or molecular imaging techniques like positron emission tomography (PET) and single-photon emission computed tomography (SPECT). Biologic and medical imaging reagents can include contrast agents, fluorescent dyes, radioactive tracers, nanoparticles, antibodies, peptides, or other molecular probes that specifically bind to the target of interest. By incorporating these reagents into imaging procedures, healthcare professionals can obtain detailed anatomical and functional information, aiding in the diagnosis, monitoring, and treatment of various diseases and conditions. The development and application of biologic and medical imaging reagents continue to advance, enabling more accurate and precise imaging for improved patient care and research purposes.
According to DIResearch's in-depth investigation and research, the global Biologic and Medical Imaging Reagents market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Biologic and Medical Imaging Reagents include Cardinal Health, Bracco, Bayer HealthCare, Curium Pharma, Hengrui Medicine, GE Healthcare, Lantheus Medical Imaging, Novartis (AAA), Thermo Fisher Scientific, Jubilant DraxImage, PerkinElmer, Guerbet, Nihon Medi-Physics, YRPG etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Biologic and Medical Imaging Reagents. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biologic and Medical Imaging Reagents market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biologic and Medical Imaging Reagents market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biologic and Medical Imaging Reagents industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Biologic and Medical Imaging Reagents Include:
Cardinal Health
Bracco
Bayer HealthCare
Curium Pharma
Hengrui Medicine
GE Healthcare
Lantheus Medical Imaging
Novartis (AAA)
Thermo Fisher Scientific
Jubilant DraxImage
PerkinElmer
Guerbet
Nihon Medi-Physics
YRPG
Biologic and Medical Imaging Reagents Product Segment Include:
Nuclear Imaging (PET & SPECT) Reagents
Magnetic Resonance Imaging (MRI) Reagents
Fluorescence Imaging Reagents
Ultrasound and X-ray Contrast Reagents
Other
Biologic and Medical Imaging Reagents Product Application Include:
Hospitals
Clinics
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Biologic and Medical Imaging Reagents Industry PESTEL Analysis
Chapter 3: Global Biologic and Medical Imaging Reagents Industry Porter’s Five Forces Analysis
Chapter 4: Global Biologic and Medical Imaging Reagents Major Regional Market Size and Forecast Analysis
Chapter 5: Global Biologic and Medical Imaging Reagents Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Biologic and Medical Imaging Reagents Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Biologic and Medical Imaging Reagents Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Biologic and Medical Imaging Reagents Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Biologic and Medical Imaging Reagents Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Biologic and Medical Imaging Reagents Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Biologic and Medical Imaging Reagents Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Biologic and Medical Imaging Reagents Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook